Testing a novel treatment for diabetes-associated ischemic foot ulceration. (Old ID 24978)
Diabetes Australia
Role
Chief Investigator
Description
5000 Australians with diabetes have a leg amputations each year. This project investigates a novel drug therapy approach to reducing the need for leg amputations within an established rodent model. The aim of the study is to assess if administration of a direct activator of adenosine-5'-monophosphate (AMP)-activated protein kinase (AMPK) will promote healing within a rat model of diabetes and limb ischaemia-associated foot ulceration.
Date
01 Jan 2020 - 31 Dec 2020
Project Type
GRANT
Keywords
peripheral artery disease;Diabetes;rodent model
Funding Body
Diabetes Australia
Amount
60000
Project Team
Joseph Moxon;Smriti Murali Krishna